Skip to main content
Log in

Prodrugs of Peptides. 13. Stabilization of Peptide Amides Against α-Chymotrypsin by the Prodrug Approach

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Various derivatives of the C-terminal amide group in N-protected amino acid and peptide amides were synthesized to assess their suitability as prodrug forms with the aim of protecting the amide or peptide bond against cleavage by α-chymotrypsin. Whereas N-acetylation, N-hydroxymethylation, and N-phthalidylation did not afford any protection but, in fact, accelerated the terminal amide bond cleavage, condensation with glyoxylic acid to produce peptidyl-α-hydroxyglycine derivatives and, to a minor extent, N-aminomethylation were found to improve the stability of the parent amides. Besides protecting the terminal, derivatized amide moiety toward cleavage by α-chymotrypsin, α-hydroxyglycine derivatization resulted in a significant protection, by a factor ranging from 5 to 75, of the internal peptide bond in various N-protected dipeptide amides. These derivatives are readily bioreversible, the conversion to the parent peptide or amino acid amide taking place either by spontaneous hydrolysis at physiological pH, as demonstrated for the N-Mannich bases, or by catalysis by plasma, as for peptidyl-α-hy-droxyglycine derivatives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. K. Wiedhaup. The stability of small peptides in the gastrointestinal tract. In D. D. Breimer and P. Speiser (eds.), Topics in Pharmaceutical Sciences, Elsevier, Amsterdam, 1981, pp. 307–324.

    Google Scholar 

  2. M. J. Humphrey and P. S. Ringrose. Peptides and related drugs: A review of their absorption, metabolism and excretion. Drug Metab. Rev. 17:283–310 (1986).

    Google Scholar 

  3. V. H. L. Lee and A. Yamamoto. Penetration and enzymatic barriers to peptide and protein absorption. Adv. Drug Deliv. Rev. 4:171–207 (1990).

    Google Scholar 

  4. H. Bundgaard. Prodrugs as a means to improve the delivery of peptide drugs. Adv. Drug Deliv. Rev. (in press).

  5. H. Bundgaard and J. Møss. Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme. Pharm. Res. 7:885–892 (1990).

    Google Scholar 

  6. J. Møss and H. Bundgaard. Prodrugs of peptides. 7. Transdermal delivery of thyrotropinreleasing hormone (TRH) via prodrugs. Int. J. Pharm. 66:39–45 (1990).

    Google Scholar 

  7. H. Bundgaard and G. J. Rasmussen. Prodrugs of peptides. 9. Bioreversible N-α-hydroxyalkylation of the peptide bond to effect protection against carboxypeptidase or other proteolytic enzymes. Pharm. Res. 8:313–322 (1990).

    Google Scholar 

  8. H. Bundgaard and G. J. Rasmussen. Prodrugs of peptides. 11. Chemical and enzymatic hydrolysis of N-acyloxymethyl derivatives of the peptide bond. Pharm. Res. 8:1238–1242 (1991).

    Google Scholar 

  9. G. P. Hess. Chymotrypsin—chemical properties and catalysis. In P. D. Boyer (ed.), The Enzymes, Vol. III, Academic Press, New York, 1971, pp. 213–248.

    Google Scholar 

  10. T. C. Bruice and S. Benkovic. Bioorganic Mechanisms, Vol. I, W. A. Benjamin, New York, 1966, pp. 212–258.

    Google Scholar 

  11. C. Hansch and E. Coats. α-Chymotrypsin: A case study of substituent constants and regression analysis in enzymic structure-activity relationships. J. Pharm. Sci. 59:731–743 (1970).

    Google Scholar 

  12. M. L. Bender and J. V. Killheffer. Chymotrypsins. Crit. Rev. Biochem. 1:149–199 (1973).

    Google Scholar 

  13. T. Barth, V. Pliska, and I. Rycklik. Chymotryptic and tryptic cleavage of oxytocin and vasopressin. Coll. Cz. Chem. Comm. 32:1058–1063 (1967).

    Google Scholar 

  14. A. H. Kahns and H. Bundgaard. Facile α-chymotrypsin-catalyzed degradation of the HIV-inhibitor [D-Ala1]-peptide T amide. Int. J. Pharm. (1991) (in press).

  15. J. J. Plattner, P. A. Marcotte, H. D. Kleinert, H. H. Stein, J. Greer, G. Bolis, A. K. L. Fung, B. A. Bopp, J. R. Luly, H. L. Sham, D. J. Kempf, S. H. Rosenberg, J. F. Dellaria, B. De, I. Merits, and T. J. Perun. Renin inhibitors. Dipeptide analougues of angiotensinigen utilizing a structurally modified phenylalanine residue to impart proteolytic stability. J. Med. Chem. 31:2277–2288 (1988).

    Google Scholar 

  16. H. Bundgaard and A. H. Kahns. Chemical stability and plasmacatalyzed dealkylation of peptidyl-α-hydroxyglycine derivatives—intermediates in peptide α-amidation. Peptides (1991) (in press).

  17. H. Bundgaard and M. Johansen. Prodrugs as drug delivery systems. IV. N-Mannich bases as potential novel prodrugs for amides, ureides, amines and other NH-acidic compounds. J. Pharm. Sci. 69:44–46 (1980).

    Google Scholar 

  18. H. Bundgaard. Formation of prodrugs of amines, amides, ureides and imides. Meth. Enzymol. 112:347–359 (1985).

    Google Scholar 

  19. A. H. Kahns and H. Bundgaard. N-Acyl derivatives as prodrug forms for amides: Chemical stability and enzymatic hydrolysis of various N-acyl and N-alkoxycarbonyl amide derivatives. Int. J. Pharm. 71:31–43 (1991).

    Google Scholar 

  20. R. D. Haworth, D. H. Peacock, W. R. Smith, and R. MacGillivray. The action of formaldehyde on proteins. II. Some reactions of N-hydroxymethylamides. J. Chem. Soc. 2972–2980 (1952).

  21. D. D. Wheeler, D. C. Young, and D. S. Erley. Reactions of phthalaldehydic acid. J. Org. Chem. 22:547–556 (1957).

    Google Scholar 

  22. H. Bundgaard. Design of prodrugs: Bioreversible derivatives for various functional groups and chemical entities. In H. Bundgaard (ed.), Design of Prodrugs, Elsevier, Amsterdam, 1985, pp. 1–92.

    Google Scholar 

  23. H. Bundgaard and A. Buur. Prodrugs as drug delivery systems 65. Hydrolysis of α-acyloxy-N-benzoylglycine derivatives and implications for the design of prodrugs of NH-acidic compounds. Int. J. Pharm. 37:185–194 (1987).

    Google Scholar 

  24. H. Bundgaard, A. Buur, K. T. Hansen, J. D. Larsen, J. Møss, and L. Olsen. Prodrugs as drug delivery systems. 77. Phthalidyl derivatives as prodrug forms for amides, sulfonamides, carbamates and other NH-acidic compounds. Int. J. Pharm. 45:47–57 (1988).

    Google Scholar 

  25. F. E. Brot and M. L. Bender. Use of the specificity constant of α-chymotrypsin. J. Am. Chem. Soc. 91:7187–7191 (1969).

    Google Scholar 

  26. W. E. M. Lands and C. Niemann. The interaction of α-chymotrypsin with a series of α-N-acylated-L-tyrosinmethylamides. J. Am. Chem. Soc. 81:2204–2208 (1959).

    Google Scholar 

  27. T. H. Applewhite and C. Niemann. The interaction of α-chymotrypsin with a series of α-N-acetyl-α-amino acid methylamides. J. Am. Chem. Soc. 81:2208–2213 (1959).

    Google Scholar 

  28. K. Morihara and T. Oka. A kinetic investigation of subsites S1‰ and S2‰ in α-chymotrypsin and subtilisin BPN. Arch. Biochem. Biophys. 178:188–194 (1977).

    Google Scholar 

  29. J. A. Hartsuck and W. N. Lipscomb. Carboxypeptidase A. In P. D. Boyer (ed.), The Enzymes, Vol. III, Academic Press, New York, 1971, pp. 1–56).

    Google Scholar 

  30. B. A. Eipper and R. E. Mains. Peptide α-amidation. Annu. Rev. Physiol. 50:333–344 (1988).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kahns, A.H., Bundgaard, H. Prodrugs of Peptides. 13. Stabilization of Peptide Amides Against α-Chymotrypsin by the Prodrug Approach. Pharm Res 8, 1533–1538 (1991). https://doi.org/10.1023/A:1015854718903

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015854718903

Navigation